132
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Response to letter to the editor from Elinder and Nordberg concerning Byber et al. 2016. Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review, Crit Rev Toxicol. 46(3):191–240. DOI: 0.3109/10408444.2015.1076375

, , , &
Pages 906-907 | Received 01 Sep 2017, Accepted 01 Sep 2017, Published online: 16 Oct 2017
 
View correction statement:
Erratum

Declaration of interest

The authors declare that they have no actual or potential competing financial interest. Part of this work has been conducted by order of the Ministry of Social Affairs, Public Health and Environment (Belgium), within the scope of the EC Council Regulation (EC)793/93, requiring the risk assessment of existing substances. The funding source played no role in study design; in the collection, analysis, and interpretation of data, the writing of the report or approval of the manuscript, and in the decision to submit the paper for publication. The review strategy, the conduct of the review and the interpretation and synthesis of the findings were exclusively the work of the authors. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication of the original paper and this Response to a Letter to the Editor.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.